-
Product Insights
Raritan Solar Park
Raritan Solar Park is a solar PV project located in New Jersey, United States. The project is owned and developed by EffiSolar Energy Corporation. The project came online in 2018. Empower your strategies with our Raritan Solar Park report and make more profitable business decisions. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to 3 business day of the purchase, excluding weekends and holidays. Certain sections of the report...
-
Product Insights
Raritan Solar Park 1
Raritan Solar Park 1 is a solar PV project located in New Jersey, United States. The project is owned by Goldman Sachs Asset Management LP and was developed by Marina Energy LLC; Unity Electric LLC. The project came online in 2016. Empower your strategies with our Raritan Solar Park 1 report and make more profitable business decisions. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to 3 business day...
-
Product Insights
Raritan 53 Highway Solar PV Park
Raritan 53 Highway Solar PV Park is a solar PV project located in New Jersey, United States. The project is owned and developed by NJR Clean Energy Ventures Corp. The project came online in 2018. Empower your strategies with our Raritan 53 Highway Solar PV Park report and make more profitable business decisions. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to 3 business day of the purchase, excluding...
-
Sector Analysis
Contract Pharmaceutical Dose Manufacturing Industry – Composition, Size, Market Share and Outlook, 2023 Edition
Contract Pharmaceutical Dose Manufacturing Industry Overview The total dose CMO contract revenue in 2022 represented significant growth over 2021 revenue. The growth rate was the highest recorded since 2011 for commercial contract dose manufacturing revenues, and surprisingly adds to the strong growth experienced in 2021, despite demand for COVID-19 vaccines and therapies waning in 2022. The Contract Pharmaceutical Dose Manufacturing Industry report is a comprehensive look at the finished dose contract manufacturing landscape in 2023. It includes an analysis of...
-
Company Profile
Ortho Clinical Diagnostics Holdings Plc – Company Profile
Ortho Clinical Diagnostics Holdings Plc (OCD), a subsidiary of Quidelortho Corp, designs, develops, manufactures and markets diagnostic instruments, assays. It offers its products and solutions to hospitals, clinical laboratories, blood, and plasma centers across the world. The company’s products include clinical chemistry products used for measurement of target chemicals in bodily fluids for the evaluation of health and the clinical management of patients; and Immunoassays for measurement of proteins, antibodies, and markers; donor screening and immunohematology products for blood and...
Add to Basket -
Product Insights
Ortho Clinical Diagnostics Holdings Plc Pipeline Insight and Competitive Landscape, 2023
Empower your strategies with our Ortho Clinical Diagnostics Holdings Plc Pipeline Insight and Competitive Landscape, 2023 report and make more profitable business decisions. Ortho Clinical Diagnostics Holdings Plc (OCD) designs, develops, manufactures, and markets diagnostic instruments, assays. It offers its products and solutions to hospitals, clinical laboratories, blood, and plasma centers across the world. The company’s products include clinical chemistry products used for measurement of target chemicals in bodily fluids for the evaluation of health and the clinical management of...